scholarly article | Q13442814 |
P2093 | author name string | Weijia Wang | |
Hua Zhu | |||
Shannon L Taylor | |||
Robert Morton | |||
Jennifer F Moffat | |||
Stacey A Leisenfelder | |||
Sergey Smirnov | |||
P2860 | cites work | Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome | Q24645354 |
Functional profiling of a human cytomegalovirus genome | Q28185252 | ||
An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
The SCID-hu xenogeneic transplantation model: complex but telling | Q33730764 | ||
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression | Q33815575 | ||
Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue. | Q33821235 | ||
Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system | Q33854329 | ||
Functional map of human cytomegalovirus AD169 defined by global mutational analysis | Q33972886 | ||
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse | Q34069075 | ||
Candidate cytomegalovirus strain for human vaccination | Q34126497 | ||
A review of genetic differences between limited and extensively passaged human cytomegalovirus strains | Q34263661 | ||
Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene | Q34971048 | ||
Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice | Q35845405 | ||
Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle | Q35886438 | ||
Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication | Q36030112 | ||
Cytomegalovirus encodes a potent alpha chemokine | Q36436978 | ||
Animal cytomegaloviruses | Q37056341 | ||
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. | Q39595874 | ||
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes | Q39602194 | ||
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. | Q39874671 | ||
Immunisation trials with live attenuated cytomegalovirus TOWNE 125 | Q39957282 | ||
Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus | Q40027641 | ||
A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family | Q40308946 | ||
Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line | Q40622625 | ||
The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. | Q41178997 | ||
The SCID-hu mouse: an in vivo model for HIV-1 infection in humans | Q41521953 | ||
Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue | Q43652249 | ||
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. | Q43762083 | ||
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors | Q43769307 | ||
Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial | Q43829415 | ||
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function | Q44322674 | ||
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus | Q45239101 | ||
Cytomegalovirus vaccine virus (Towne strain) does not induce latency | Q45838273 | ||
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge | Q46111260 | ||
Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. | Q52116864 | ||
Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. | Q53884793 | ||
Cytomegalovirus infection of human retinal tissue: an in vivo model | Q72083686 | ||
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice | Q72283671 | ||
Vaccination of pediatric nurses with live attenuated cytomegalovirus | Q72928273 | ||
Rapid engineering of bacterial artificial chromosomes using oligonucleotides | Q73339514 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2115-2123 | |
P577 | publication date | 2005-02-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice | |
P478 | volume | 79 |
Q40474474 | A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. |
Q36355613 | Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model |
Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
Q38767171 | Functional analysis of human cytomegalovirus UL/b' region using SCID-hu mouse model |
Q33892537 | Functional interaction of nuclear domain 10 and its components with cytomegalovirus after infections: cross-species host cells versus native cells |
Q33912815 | Human Cytomegalovirus Latency: Approaching the Gordian Knot |
Q34192857 | Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection |
Q36142747 | Humanized mouse models of human cytomegalovirus infection |
Q40971095 | Identification and BAC construction of Han, the first characterized HCMV clinical strain in China |
Q37145244 | Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus |
Q36172152 | Interactions between proteins encoded within the human cytomegalovirus UL133-UL138 locus. |
Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
Q38200419 | Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. |
Q39545359 | The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses. |
Q24300688 | The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism |
Q35584029 | The human cytomegalovirus UL133-138 gene locus attenuates the lytic viral cycle in fibroblasts |
Q35363103 | The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. |
Q34052098 | Transcriptional features and transcript structure of UL145 in different strains of human cytomegalovirus |
Q42257417 | Use of recombination-mediated genetic engineering for construction of rescue human cytomegalovirus bacterial artificial chromosome clones |